In this issue:
Outpatient vs. inpatient treatment for acute PE
Idrabiotaparinux vs. warfarin for acute PE
Fondaparinux for SVT
Pharmacological and compression therapies for PTS
Autoimmune disorders increase PE risk
VTE with prophylaxis after hip/knee arthroplasty
Long-term sildenafil in PAH
Ocular safety of longterm sildenafil for PAH
CAMPHOR for Australasian PAH patients
REVEAL risk scores in newly diagnosed PAH
Please login below to download this issue (PDF)